Pioneering Genomic Research Study into Asthma is Launched in Ireland

By | GMI News | No Comments

  • Genomics Medicine Ireland collaborating with St. Vincent’s University Hospital and University College Dublin to investigate one of Ireland’s most common ailments
  • Study aims to lead to more accurate diagnoses and more personalised treatments for patients

Irish life sciences company Genomics Medicine Ireland Ltd (GMI) today announced the launch of a landmark and nationwide study to examine the genomic basis of chronic respiratory conditions, such as asthma, and Asthma-COPD Overlap (ACO), in collaboration with St. Vincent’s University Hospital and University College Dublin (UCD).

Read More